Skip to main content

Main menu

  • Home
  • Issues
    • Issue in progress
    • Issues by date
  • Sections
    • Editorial
    • Review
    • Research
    • Commentary
    • Psychopharmacology for the Clinician
    • Letters to the Editor
  • Topic Collections
  • Instructions for Authors
    • Overview for authors
    • Submission checklist
    • Editorial policies
    • Publication fees
    • Submit a manuscript
    • Dr. Francis Wayne Quan Memorial Prize
    • Open access
  • Alerts
    • Email alerts
    • RSS
  • About
    • General information
    • Staff
    • Editorial Board
    • Contact
  • CMAJ JOURNALS
    • CMAJ
    • CMAJ Open
    • CJS
    • JAMC

User menu

Search

  • Advanced search
JPN
  • CMAJ JOURNALS
    • CMAJ
    • CMAJ Open
    • CJS
    • JAMC
JPN

Advanced Search

  • Home
  • Issues
    • Issue in progress
    • Issues by date
  • Sections
    • Editorial
    • Review
    • Research
    • Commentary
    • Psychopharmacology for the Clinician
    • Letters to the Editor
  • Topic Collections
  • Instructions for Authors
    • Overview for authors
    • Submission checklist
    • Editorial policies
    • Publication fees
    • Submit a manuscript
    • Dr. Francis Wayne Quan Memorial Prize
    • Open access
  • Alerts
    • Email alerts
    • RSS
  • About
    • General information
    • Staff
    • Editorial Board
    • Contact
  • Subscribe to our alerts
  • RSS feeds
  • Follow JPN on Twitter
Psychopharmacology for the Clinician

Subacute alteration in level of consciousness in a woman with psychotic depression

Zainab Samaan and Glenda MacQueen
J Psychiatry Neurosci May 01, 2008 33 (3) E1-E2;
Zainab Samaan
Department of Psychiatry and Behavioural, Neurosciences, McMaster University, Hamilton, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Glenda MacQueen
Department of Psychiatry and Behavioural, Neurosciences, McMaster University, Hamilton, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

Hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion (SIADH) is an unusual cause of altered consciousness, although it has been described after treatment with various psychotropic medications. Clinicians therefore need to consider SIADH when patients taking psychotropic medications present with otherwise unexplained changes in their level of consciousness.

NS was a 33-year-old single woman taken by her father to the emergency department. She was obtunded and unable to provide a history, with a Glasgow Coma Scale of 9 and no focal neurologic signs. NS was admitted to the intensive care unit for investigation and stabilization.

NS had a 7-year history of psychotic symptoms associated with depressive episodes. Symptom onset coincided with a clinical presentation of Cushing’s syndrome, likely secondary to a left adrenal adenoma. The peripheral Cushingoid features resolved after successful left adrenalectomy 5 years before this hospitalization. NS received steroids only for 2 years after the unilateral adrenalectomy, after which her cortisol levels were maintained within the normal range. NS had acid reflux disease and had been treated with pantoprazole for several years, which included the time of presentation. Over time, NS had been treated with multiple antidepressants and antipsychotic medications, including bupropion SR up to a total of 450 mg daily, with partial response. Bupropion had been discontinued a year before this episode and restarted before this presentation. NS was taking quetiapine 300 mg and diazepam 20 mg daily for several months preceding admission. Buproprion was increased over 2 weeks, from 150 mg to 300 mg daily, after which NS began to show the signs of an altered level of consciousness that resulted in hospitalization.

A computed tomography scan of her brain on admission revealed no abnormality, and lumbar puncture results were within normal ranges. Laboratory investigations revealed normal blood pH (7.46), low serum sodium (Na+) at 112 mmol/L, normal potassium (K+) at 3.5 mmol/L, low chloride at 79 mmol/L, low serum osmolality at 240 mOsm/kg, high urine osmolality at 468 mOsm/kg and high urinary Na+ at 82 mmol/L. Random cortisol was elevated at 927 nmol/L, reflecting an appropriate reaction to stress. Anion gap, complete blood count, thyroid-stimulating hormone, renal function and serum prolactin (12 ng/mL) were all normal. Sodium levels were corrected, and NS was discharged without further incident.

Differential diagnoses included SIADH or SIADH-like syndrome; the preferred diagnosis was SIADH because there was no evidence for renal tubular acidosis. SIADH is diagnosed when serum osmolality is inappropriately lower than urine osmolality, with normal to high urinary Na+ and hyponatremia. 1 SIADH has various causes, including antiepileptic and psychotropic medications that can stimulate the secretion of antidiuretic hormone (ADH) or potentiate its actions. 2 In this case, it is plausible that the increase in bupropion contributed to the development of SIADH. Bupropion has been associated with hyponatremia in at least 2 reported cases. In one, the patient was also taking antiepileptic medications. The other case described significant dietary modifications without further information. Both describe a gradual reduction in serum Na+ levels, and the hyponatremia was not as extreme as in our case (> 124 mmol/L). The possible contributing factors of concurrent medication use and the adrenelectomy must also be considered in this case.

The mechanism of action of psychotropic medications on ADH is unknown. ADH is secreted by septoptic and paraventricular nuclei in the hypothalamus and transmitted via neuronal axons to the posterior pituitary. Hyponatremia induced by antiepilectics may result from increased secretion of ADH and increased distal collecting tubule sensitivity to ADH. Whether this can occur with bupropion is undetermined.

A history of complex psychiatric symptoms can sometimes delay thorough medical investigation of changes in a patient’s mental status. In this case, there were no typical clinical features to suggest a priori that hyponatremia was the likely cause of the altered mental status.3 This case therefore emphasizes the importance of rapidly identifying and thoroughly investigating alterations in any patient’s level of consciousness.

Footnotes

  • The information in this column is not intended as a definitive treatment strategy but as a suggested approach for clinicians treating patients with similar histories. Individual cases may vary and should be evaluated carefully before treatment is provided.

  • Psychopharmacology for the Clinician columns are usually based on a case report that illustrates a point of interest in clinical psychopharmacology. They are about 500–650 words long and do not include references. Columns can include a bibliography which will be available only at the journal Web site and can be accessed through a link at the bottom of the column. Please submit appropriate columns online at http://mc.manuscriptcentral.com/jpn; inquiries may be directed to jpn{at}cma.ca.

  • Competing interests: None declared for Ms. Samaan. Dr. MacQueen has received speaker fees from Boehringer, GlaxoSmith-Kline, Organon, Novartis, Wyeth, Eli Lilly, AstraZeneca, Lundbeck, Janssen and Servier.

References

  1. ↵
    1. Ellison DH,
    2. Berl T
    . Clinical practice. The syndrome of inappropriate antidiuresis. N Engl J Med 2007;356:2064–72)
    OpenUrlCrossRefPubMed
  2. ↵
    1. Blass DM,
    2. Pearson VE
    . SIADH with multiple antidepressants in a geriatric patient. J Clin Psychiatry 2000;61:448–9)
    OpenUrlCrossRefPubMed
  3. ↵
    1. Lien YH,
    2. Shapiro JI
    . Hyponatremia: clinical diagnosis and management. Am J Med 2007;120:653–8)
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Journal of Psychiatry and Neuroscience: 33 (3)
J Psychiatry Neurosci
Vol. 33, Issue 3
1 May 2008
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on JPN.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Subacute alteration in level of consciousness in a woman with psychotic depression
(Your Name) has sent you a message from JPN
(Your Name) thought you would like to see the JPN web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Subacute alteration in level of consciousness in a woman with psychotic depression
Zainab Samaan, Glenda MacQueen
J Psychiatry Neurosci May 2008, 33 (3) E1-E2;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Subacute alteration in level of consciousness in a woman with psychotic depression
Zainab Samaan, Glenda MacQueen
J Psychiatry Neurosci May 2008, 33 (3) E1-E2;
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

Similar Articles

Content

  • Current issue
  • Past issues
  • Collections
  • Alerts
  • RSS

Authors & Reviewers

  • Overview for Authors
  • Submit a manuscript
  • Manuscript Submission Checklist

About

  • General Information
  • Staff
  • Editorial Board
  • Contact Us
  • Advertising
  • Reprints
  • Copyright and Permissions
  • Accessibility
  • CMA Civility Standards
CMAJ Group

Copyright 2022, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1180-4882.

All editorial matter in JPN represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.
To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected].
View CMA's Accessibility policy.

Powered by HighWire